We provide you with 20 years of free, institutional-grade data for PMVP stock, allowing you to gain comprehensive visibility into the fundamentals of the company. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of PMVP. Explore the full financial landscape of PMVP stock.
Total insider purchase within 3 month on this page: $0
Total insider selling within 3 month on this page: -$0
| Name | Action | Shares | Avg Price | Amount | Reported Date |
|---|
The information provided in this report about PMVP stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
PMV Pharmaceuticals, Inc(NASDAQ:PMVP) 
PMV Pharmaceuticals, Inc., a precision oncology company, engages in the discovery and development of small molecule, tumor-agnostic therapies for p53 mutations in cancer. The company's lead product candidate is PC14586, a small molecule that corrects a p53 protein containing the Y220C mutation and r...
Website: http://www.pmvpharma.com
Full Time Employees: 39
CEO: David H. Mack
Sector: Healthcare
Industry: Biotechnology
Share this website to your friends